WPD PHARMACEUTICALS

WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) has no active business operations currently. The Company's sole asset is shares in its former subsidiary in Poland named WPD Pharmaceuticals Sp. zo.o. The Company lost control of the Polish company on November 25, 2022 as a result of a restructuring. The Company's shares in the Polish company currently represent approximately 7% of the total issued shares of the Polish company. The Polish company is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules... WPD focuses on developing biological and chemical molecules involved in targeted therapy for brain glioma and other central nervous system cancers.

Also known as: WPD, WPD Pharmaceuticals Inc., WPD Pharmaceuticals Sp

Primary location: Vancouver Canada